Lannett Co. has appointed Maureen Cavanaugh as the new senior vice president and chief commercial operations officer, a role from which she will oversee the company’s sales and marketing, R&D and regulatory affairs.
“Maureen brings nearly 30 years of pharmaceutical industry experience, having served in senior level positions with some of the world’s largest and most highly regarded generic and innovative drug companies,” Lannett CEO Tim Crew said. “Maureen is extremely skilled at building and leading high-performing businesses and has broad expertise across a number of operational functions, especially planning and executing new product launches, strategic product management, identifying portfolio opportunities and coordinating activities between key functional areas within an organization.”
Cavanaugh recently worked for Teva Pharmaceuticals USA as senior vice president and served as chief commercial officer for North America Generics for 11 years before that.
Apart from Cavanaugh’s appointment, the company is reshuffling other management responsibilities. Among newly assigned personnel are John Kozlowski and John Abt.
Kozlowski, who joined Lannett since 2009, is the company’s new chief of staff and strategy officer. Abt, will serve as head of production, supply chain, and quality.
